Tardive blepharospasm associated with cinnarizine use.
To report a patient with chronic blepharospasm possibly induced by the calcium-channel blocker cinnarizine. A 53-year-old woman developed chronic blepharospasm during a prolonged therapy with calcium-channel blocker cinnarizine for the treatment of vertigo. "Tardive blepharospasm" should be considered as a possible adverse effect of cinnarizine.